🇺🇸 FDA
Patent

US 8580263

Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof

granted A61KA61K2039/505A61K47/6849

Quick answer

US patent 8580263 (Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof) held by The Regents of the University of California expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K47/6849, A61K47/6879, A61K49/0017